Literature DB >> 6903189

Chemotactic activity of elastin-derived peptides.

R M Senior, G L Griffin, R P Mecham.   

Abstract

Elastin-derived peptides, produced by digesting human aortic elastin and bovine ligament elastin with human neutrophil elastase, were tested for chemotactic activity. At 100 micrograms protein/ml, elastin digests were nearly as active for monocytes as saturating amounts of complement-derived chemotactic activity. Neutrophils and alveolar macrophages showed less response to elastin peptidces than did monocytes. Fractionation of the digests by gel filtration chromatography disclosed that maximal chemotactic activity eluted in fractions corresponding to 14,000-20,000 mol wt containing most of the desmosine cross-links in the digests. Whole human serum and rabbit anti-elastin immunoglobulin inhibited the chemotactic activity. Purified desmosine also showed chemotactic activity for monocytes, maximal at 10 nM. These findings suggest that elastin-degradation products enriched in cross-linking regions recruit inflammatory cells in vivo and that elastin proteolysis, characteristic of emphysema, may be a signal for recruitment of mononuclear phagocytes into the lungs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6903189      PMCID: PMC371663          DOI: 10.1172/JCI109926

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  A large scale procedure for purification of desmosine and isodesmosine.

Authors:  B C Starcher; M J Galione
Journal:  Prep Biochem       Date:  1975

2.  Comparison of the elastolytic effects of human leukocyte elastase and porcine pancreatic elastase.

Authors:  R M Senior; D R Bielefeld; B C Starcher
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

3.  Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides.

Authors:  A E Postlethwaite; J M Seyer; A H Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

4.  An improved method for the in vitro evaluation of monocyte leukotaxis.

Authors:  P B Campbell
Journal:  J Lab Clin Med       Date:  1977-08

5.  Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers.

Authors:  R J Rodriguez; R R White; R M Senior; E A Levine
Journal:  Science       Date:  1977-10-21       Impact factor: 47.728

6.  A rapid procedure for the large scale purification of elastase and cathepsin G from human sputum.

Authors:  R R Martodam; R J Baugh; D Y Twumasi; I E Liener
Journal:  Prep Biochem       Date:  1979

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Isolation by hydrophobic chromatography of the chemotactic factor inactivators from human serum.

Authors:  D L Kreutzer; W D Claypool; M L Jones; P A Ward
Journal:  Clin Immunol Immunopathol       Date:  1979-02

9.  Characterization of insoluble elastin from copper-deficient pigs. Its usefulness in elastin sequence studies.

Authors:  R P Mecham; J A Foster
Journal:  Biochim Biophys Acta       Date:  1979-03-27

10.  Collagen-and collagen peptide-induced chemotaxis of human blood monocytes.

Authors:  A E Postlethwaite; A H Kang
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  122 in total

Review 1.  Recent advances in molecular biological techniques and their relevance to pulmonary research.

Authors:  B W Robinson; D J Erle; D A Jones; S Shapiro; W J Metzger; S M Albelda; W C Parks; A Boylan
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

Authors:  G E Davis; K J Bayless; M J Davis; G A Meininger
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 3.  Factors influencing airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Hill; S Gompertz; R Stockley
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 4.  Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.

Authors:  David A Lomas; Ravi Mahadeva
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

5.  Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.

Authors:  Frank M Davis; Debra L Rateri; Anju Balakrishnan; Deborah A Howatt; Dudley K Strickland; Selen C Muratoglu; Christopher M Haggerty; Brandon K Fornwalt; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

Review 6.  Fine tuning of cell behaviour by modulation of plasma membrane receptors.

Authors:  D Burnett
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

Review 7.  Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema.

Authors:  R Mahadeva; S D Shapiro
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 8.  The impact of the extracellular matrix on inflammation.

Authors:  Lydia Sorokin
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

9.  High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine.

Authors:  Michel Boutin; Carl Berthelette; François G Gervais; Mary-Beth Scholand; John Hoidal; Mark F Leppert; Kevin P Bateman; Pierre Thibault
Journal:  Anal Chem       Date:  2009-03-01       Impact factor: 6.986

10.  Coronary Artery Remodeling and Fibrosis With Continuous-Flow Left Ventricular Assist Device Support.

Authors:  Amrut V Ambardekar; Mary C M Weiser-Evans; Marcella Li; Suneet N Purohit; Muhammad Aftab; T Brett Reece; Karen S Moulton
Journal:  Circ Heart Fail       Date:  2018-05       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.